Paper
0
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
Authors
Journal
Published
Dec 31, 2014
Show more
Save
Tip0
TipSave
Abstract
Key Points The presence of a mutation in SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, or STAG2 is highly specific for secondary AML. Secondary-type mutations define an s-AML–like disease within t-AML and elderly de novo AML that underlies clinical heterogeneity.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.